The Human Proteome Organization (HUPO) is an international scientific organization representing and promoting proteomics through international cooperation and collaborations by fostering the development of new technologies, techniques and training.
HUPO Mission Statement
To define and promote proteomics through international cooperation and collaborations by fostering the development of new technologies, techniques and training to better understand human disease.
How did HUPO evolve?
HUPO was launched on February 9, 2001. On that date, a global advisory council was officially formed that included leading global experts in the field of proteomics from the academic, government, and commercial sectors. Over the next 12 months, the council, in consultation with industry, identified major proteomics issues and initiatives that needed to be addressed by HUPO. Since its inception, HUPO has received substantial financial assistance from Genome Quebec, Montreal International, McGill University, the National Institutes of Health, and pharmaceutical companies, among others. In addition, it has benefited from considerable in-kind contributions of time and energy from HUPO Council members, research institutes, and pharmaceutical company partners around the world.
HUPO Initiatives are prominently showcased at each Annual HUPO World Congress, which are held as per a three year rotation in the Americas, Asia/Oceania and Europe. Past congresses have been held in cities such as Versailles, France (2002), Montreal, Canada (2003), Beijing, China (2004), Munich, Germany (2005). Long Beach, USA (2006), Seoul, Korea (2007), Amsterdam, The Netherlands (2008) and Toronto, Canada (2009). The number of participants and exhibitors has significantly increased over the years and the Congresses are a must attend for anyone involved in proteomics.
The HUPO Office Headquarters are located in Vancouver, BC, Canada.